Smad3 is required for enamel biomineralization

Biochemical and Biophysical Research Communications

Volumn 305, Issue 3, 2003, Pages 684-690

  Yokozeki, Masahiko ^a   Afanador, Elaine ^a   Nishi, Masumi ^a   Kaneko, Kazuyuki ^a   Shimokawa, Hitoyata ^b   Yokote, Koutaro ^c   Deng, Chuxia ^d   Tsuchida, Kunihiro ^a   Sugino, Hiromu ^a   Moriyama, Keiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Enamel; Hypomineralization; Smad3; Tooth development

Indexed keywords

SMAD3 PROTEIN;

AMELOBLAST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMINERALIZATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENAMEL; GENE DELETION; GENE TARGETING; INCISOR; MICROCOMPUTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; WILD TYPE;

EID: 0038393018     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00806-4     Document Type: Article

References (35)

1. Bartlett J.D., Simmer J.P. Proteinases in developing dental enamel. Crit. Rev. Oral Biol. Med. 10(4):1999;425-441.
2. Simmer J.P., Hu J.C. Expression, structure, and function of enamel proteinases. Connect. Tissue Res. 43(2-3):2002;441-449.
3. Massague J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
4. Ten Dijke P., Goumans M.J., Itoh F., Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191(1):2002;1-16.
5. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J. 18(5):1999;1280-1291.
6. Wright J.T., Kiefer C.L., Hall K.I., Grubb B.R. Abnormal enamel development in a cystic fibrosis transgenic mouse model. J. Dent. Res. 75(4):1996;966-973.
7. Zhou H.M., Nichols A., Wohlwend A., Bolon I., Vassalli J.D. Extracellular proteolysis alters tooth development in transgenic mice expressing urokinase-type plasminogen activator in the enamel organ. Development. 126(5):1999;903-912.
8. Gibson C.W., Yuan Z.A., Hall B., Longenecker G., Chen E., Thyagarajan T., Sreenath T., Wright J.T., Decker S., Piddington R., Harrison G., Kulkarni A.B. Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. J. Biol. Chem. 276(34):2001;31871-31875.
9. Lyngstadaas S.P., Risnes S., Sproat B.S., Thrane P.S., Prydz H.P. A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo. EMBO J. 14(21):1995;5224-5229.
10. Paine M.L., Zhu D.H., Luo W., Bringas P. Jr., Goldberg M., White S.N., Lei Y.P., Sarikaya M., Fong H.K., Snead M.L. Enamel biomineralization defects result from alterations to amelogenin self-assembly. J. Struct. Biol. 132(3):2000;191-200.
11. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell Biol. 19(4):1999;2495-2504.
12. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.L., Mizel D.E., Anzano M., Greenwell-Wild T., Wahl S.M., Deng C., Roberts A.B. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1(5):1999;260-266.
13. Zhu Y., Richardson J.A., Parada L.F., Graff J.M. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 94(6):1998;703-714.
14. Yang X., Chen L., Xu X., Li C., Huang C., Deng C.X. TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153(1):2001;35-46.
15. Borton A.J., Frederick J.P., Datto M.B., Wang X.F., Weinstein R.S. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J. Bone Miner. Res. 16(10):2001;1754-1764.
16. Witkop C.J. Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J. Oral Pathol. 17(9-10):1988;547-553.
17. Backman B. Amelogenesis imperfecta-clinical manifestations in 51 families in a northern Swedish county. Scand. J. Dent. Res. 96:1988;505-516.
18. Aldred M.J., Crawford P.J., Roberts E., Thomas N.S. Identification of a nonsense mutation in the amelogenin gene (AMELX) in a family with X-linked amelogenesis imperfecta (AIH1). Hum. Genet. 90:1992;413-416.
19. Lench N.J., Brook A.H., Winter G.B. SSCP detection of a nonsense mutation in exon 5 of the amelogenin gene (AMGX) causing X-linked amelogenesis imperfecta (AIH1). Hum. Mol. Genet. 3:1994;827-828.
20. Rajpar M.H., Harley K., Laing C., Davies R.M., Dixon M.J. Mutation of the gene encoding the enamel-specific protein, enamelin, causes autosomal-dominant amelogenesis imperfecta. Hum. Mol. Genet. 10:2001;1673-1677.
21. Mardh C.K., Backman B., Holmgren G., Hu J.C., Simmer J.P., Forsman-Semb K. A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (AIH2). Hum. Mol. Genet. 11:2002;1069-1074.
22. D'Souza R.N., Cavender A., Dickinson D., Roberts A., Letterio J. TGF-β1 is essential for the homeostasis of the dentin-pulp complex. Eur. J. Oral. Sci. 106(Suppl. 1):1998;185-191.
23. Ito Y., Sarkar P., Mi Q., Wu N., Bringas P. Jr., Liu Y., Reddy S., Maxson R., Deng C., Chai Y. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-β-mediated epidermal homeostasis. Dev. Biol. 236:2001;181-194.
24. Arquitt C.K., Boyd C., Wright J.T. Cystic fibrosis transmembrane regulator gene (CFTR) is associated with abnormal enamel formation. J. Dent. Res. 81:2002;492-496.
25. Kelley T.J., Elmer H.L., Corey D.A. Reduced Smad3 protein expression and altered transforming growth factor- β1-mediated signaling in cystic fibrosis epithelial cells. Am. J. Respir. Cell Mol. Biol. 25:2001;732-738.
26. ten Dijke P., Miyazono K., Heldin C.H. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8(2):1996;139-145.
27. Dick A., Risau W., Drexler H. Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development. Dev. Dyn. 211:1998;293-305.
28. Flanders K.C., Kim E.S., Roberts A.B. Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev. Dyn. 220(2):2001;141-154.
29. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 393:1998;786-790.
30. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell. 92:1998;797-808.
31. Weinstein M., Yang X., Li C., Xu X., Gotay J., Deng C.X. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. USA. 95:1998;9378-9383.
32. Heyer J., Escalante-Alcalde D., Lia M., Boettinger E., Edelmann W., Stewart C.L., Kucherlapati R. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci. USA. 96:1999;12595-12600.
33. Ferguson C.A., Tucker A.S., Heikinheimo K., Nomura M., Oh P., Li E., Sharpe P.T. The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and Smad2, in patterning of tooth development. Development. 128:2001;4605-4613.
34. Ito Y., Zhao J., Mogharei A., Shuler C.F., Weinstein M., Deng C., Chai Y. Antagonistic effects of Smad2 versus Smad7 are sensitive to their expression level during tooth development. J. Biol. Chem. 276:2001;44163-44172.
35. Caterina J.J., Skobe Z., Shi J., Ding Y., Simmer J.P., Birkedal-Hansen H., Bartlett J.D. Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J. Biol. Chem. 277(51):2002;49598-49604.